Dyslipidemia
Learn about the latest trends, discover events and innovations in the changing world of dyslipidemia disease.
Science in Dyslipidemia Disease
Get a 360º view and stay up-to-date on cardiovascular disease with content selected for you
PCSK9i and Prevention of CVD
The synopsis of a Cochrane Systematic review on PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.
.png/jcr:content/jcr_content%20(9).png)
ACC/AHA vs ESC/EAS LDL–C recommendations for residual risk reduction in ASCVD: A simulation study from Da Vinci
Inspiration and innovation
Get inspired and stay at the forefront of innovation with the following resources
PCSK9i and Prevention of CVD
The synopsis of a Cochrane Systematic review on PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.
Specific Patient Characteristics Linked to Below Average Quality of Life in Patients with Recent Venous Thromboembolism (VTE)
Many associated factors are modifiable indicating potential benefit from planned strategies.
Risk for Pulmonary Embolism Continues Beyond 6 Weeks of Surgery
Guidelines recommend postoperative prophylactic anticoagulation for 1-5 weeks.
VTE Comparison of Pregnancy - Specific Risk Scoring Systems in Hospitalized Maternity Patients
Large prospective clinical trials are needed to validate the scoring threshold for pharmacoprophylaxis.
Utility of Pregnancy - Adapted Years Algorithm in Diagnosis of Pulmonary Embolism
Findings from a multicentre prospective Artemis study.
ACC/AHA vs ESC/EAS LDL–C recommendations for residual risk reduction in ASCVD: A simulation study from Da Vinci
Events
Stay up to date and register for the latest events and view webinar recordings.